CHD vs CL Stock Comparison: AI Score, Valuation, Performance and Upside
Church & Dwight and Colgate-Palmolive both compete in household and personal care, but Church & Dwight follows a more concentrated North American portfolio-brand strategy while Colgate-Palmolive operates as a global oral and personal care leader with substantial emerging market exposure.
Church & Dwight offers a focused North American brand portfolio strategy with a track record of disciplined M&A, while Colgate-Palmolive offers global scale and emerging market exposure anchored by oral care leadership. Consider whether you prefer Church & Dwight's concentrated brand strategy or Colgate's international diversification.
CL holds the edge across 4 of 5 key metrics in this comparison. CHD has delivered stronger 1-year price return (+19.37% vs +17.76%), though CL has the better forward P/E setup (22.09x vs 25.07x for CHD). CL leads on both revenue growth (4.90%) and operating margin (20.97%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for CL (+9.04%) than for CHD (+4.06%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want exposure to a portfolio strategy of acquiring and scaling niche household brands
- Believe concentrated North American focus supports deep category expertise
- Value a track record of successful brand integration
- Are comfortable with limited international diversification relative to larger peers
- Want exposure to a global oral and personal care category leader
- Believe emerging market volume growth offers a durable long-term tailwind
- Value a long dividend history supported by consistent free cash flow
- Are comfortable with currency translation effects from its international footprint
| Metric | CHD | CL |
|---|---|---|
| AI scorei | 40.6 | 42.4 |
| AI ranki | #1097 | #905 |
| Latest closei | $105.19 | $94.04 |
| 1M returni | +9.55% | +9.44% |
| 3M returni | +7.73% | +3.63% |
| 6M returni | +10.70% | +11.09% |
| 1Y returni | +19.37% | +17.76% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | CHD | CL |
|---|---|---|
| 1Y ago | $12.13K (+21.3%) started 2025-10-23 | $11.99K (+19.9%) started 2025-10-23 |
| 5Y ago | $13.72K (+37.2%) started 2021-10-25 | $14.8K (+48.0%) started 2021-10-25 |
| 10Y ago | $28.05K (+180.5%) started 2016-10-24 | $20.16K (+101.6%) started 2016-10-24 |
Hypothetical — past performance does not guarantee future results.
| Metric | CHD | CL |
|---|---|---|
| Market capi | $24.02B | $72.34B |
| Trailing P/Ei | 32.77 | 35.73 |
| Forward P/Ei | 25.07 | 22.09 |
| Price/Salesi | N/A | N/A |
| EV/Revenuei | 4.21 | 3.76 |
| Analyst targeti | $105.37 | $98.95 |
| Target upsidei | +4.06% | +9.04% |
| Metric | CHD | CL |
|---|---|---|
| Revenue growthi | 1.60% | 4.90% |
| Earnings growthi | 9.00% | -5.50% |
| EPS growthi | +9.00% | -5.50% |
| FCF margini | +15.08% | +16.43% |
| Operating margini | 18.07% | 20.97% |
| Profit margini | 11.96% | 9.68% |
| ROIC proxyi | 17.04% | 267.37% |
| Return on equityi | 17.04% | 267.37% |
| Dividend yieldi | 1.21% | 2.34% |
| Payout ratioi | 38.62% | 82.28% |
| Dividend growth streaki | No increase yet | No increase yet |
| Betai | 0.47 | 0.33 |
| Debt/equityi | 55.85 | 1388.16 |
| Current ratioi | 1.15 | 1.03 |
| Quick ratioi | 0.64 | 0.56 |
Over the past year, CHD and CL have moved strongly in the same direction (correlation of 0.72), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | CHD | CL |
|---|---|---|---|
| 1Y | Growthi | +21.31% | +19.89% |
| CAGRi | +21.35% | +19.92% | |
| Volatilityi | 23.21% | 23.20% | |
| Sharpe ratioi | 0.76 | 0.71 | |
| Sortino ratioi | 1.16 | 1.07 | |
| Max drawdowni | 13.81% | 17.48% | |
| Current drawdowni | 3.37% | 5.14% | |
| Avg drawdowni | 5.71% | 7.10% | |
| Ulcer Indexi | 6.76% | 8.67% | |
| Max daily dropi | 3.46% | 3.85% | |
| Max wkly dropi | 5.66% | 7.16% | |
| 5Y | Growthi | +31.19% | +35.91% |
| CAGRi | +5.59% | +6.34% | |
| Volatilityi | 21.18% | 19.36% | |
| Sharpe ratioi | 0.15 | 0.18 | |
| Sortino ratioi | 0.21 | 0.26 | |
| Max drawdowni | 31.72% | 29.94% | |
| Current drawdowni | 6.78% | 12.13% | |
| Avg drawdowni | 11.06% | 10.66% | |
| Ulcer Indexi | 13.52% | 13.01% | |
| Max daily dropi | 8.56% | 5.22% | |
| Max wkly dropi | 9.60% | 8.10% | |
| 10Y | Growthi | +148.91% | +61.69% |
| CAGRi | +9.55% | +4.92% | |
| Volatilityi | 22.03% | 20.05% | |
| Sharpe ratioi | 0.32 | 0.12 | |
| Sortino ratioi | 0.45 | 0.16 | |
| Max drawdowni | 31.72% | 29.94% | |
| Current drawdowni | 6.78% | 12.13% | |
| Avg drawdowni | 9.16% | 9.10% | |
| Ulcer Indexi | 11.43% | 11.25% | |
| Max daily dropi | 8.56% | 9.78% | |
| Max wkly dropi | 15.49% | 12.85% |
| Category | CHD | CL |
|---|---|---|
| Company | Church & Dwight Co., Inc. | Colgate-Palmolive Company |
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Household & Personal Products | Household & Personal Products |
| Core business | A consumer products company known for household and personal care brands built around a portfolio strategy of acquiring and growing niche brands, sold primarily in North America. | A global consumer products company known for oral care, personal care, and home care brands sold across developed and emerging markets worldwide. |
| Investor focus | Organic volume growth across its core brand portfolio, integration progress on recently acquired brands, and margin trends relative to input costs. | Global oral care market share trends, emerging market volume growth, and pricing actions relative to input cost inflation. |
- Portfolio strategy of acquiring and scaling niche household and personal care brands has driven consistent growth
- Concentrated North American focus allows for deep category and channel expertise
- Track record of successful brand integration supports confidence in continued disciplined M&A
- Leading global position in oral care provides durable brand recognition across many international markets
- Substantial emerging market exposure offers structural volume growth potential beyond developed markets
- Long dividend history reflects consistent free cash flow generation across economic cycles
- Heavier reliance on North American revenue limits international diversification relative to larger global peers
- Integration of newly acquired brands requires continued execution to realize expected growth and synergies
- Faces competition from larger global consumer products companies with greater marketing scale
- Currency translation from its large international footprint can affect reported results
- Input cost inflation across raw materials and packaging can pressure margins between pricing cycles
- Faces competition from both global consumer products peers and local oral and personal care brands
Compare more than two at a time
This page is a fixed writeup on CHD and CL. Our comparison engine is the interactive version: load up to five tickers, switch timeframes, and get the correlation, drawdown, and overlap analysis that a static page can't show.
Add three more names beside CHD and CL, mixing stocks and ETFs in the same table — useful when the real question is which of a whole peer group to own.
AI score, forward P/E, analyst target upside, operating margin, and revenue growth are scored head-to-head, with a running tally of which ticker leads on how many metrics.
Volatility, Sharpe and Sortino ratios, maximum, current, and average drawdown, Ulcer Index, and worst single-day and single-week drops across every timeframe.
Pairwise daily-return correlation for every combination, so you can see whether two holdings actually diversify each other or just move together.
A scatter plot of forward P/E against return on equity, plus drawdown and 30-day rolling volatility charts, to separate what is cheap from what is merely beaten down.
For ETFs, a top-holdings comparison that exposes hidden overlap between funds. Every comparison exports to CSV for your own spreadsheet work.
Two comparisons a week are free without an account. A 14-day trial removes the limit and adds AI price forecasts, stock rankings, saved watchlists, and the intrinsic value calculator — no credit card required.
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.